BeamMed

What BeamMed does

BeamMed Ltd. is a privately held Israeli medical device company founded in 2004 and headquartered in Petah Tikva, Israel, with a US operating subsidiary (BeamMed Inc.) in Plantation, Florida. The company develops, manufactures, and markets portable diagnostic devices for bone health and, more recently, retinal health, serving US Medicare Advantage health plans, health systems, clinics, physician offices, and retail health venues globally.

The company's core product platform is the Sunlight MiniOmni, a portable ultrasound-based bone densitometer built on BeamMed's patented Omnipath axial transmission technology, which measures the speed of ultrasonic waves along the bone's maximal strength axis and produces WHO-compliant T-score and Z-score outputs. The MiniOmni weighs under 2 pounds, connects via USB to Windows PCs, delivers results in under one minute with no radiation, and supports HEDIS OMW and OSW quality measure workflows for Medicare and Medicaid plans. The portfolio was extended in 2025 with the AI Fundus Camera, an FDA-cleared handheld retinal imaging device paired with cloud-based AI analysis for diabetic retinopathy detection, reimbursable under CPT code 922291.

BeamMed monetizes primarily through direct enterprise sales of hardware devices to health plans and providers, supplemented by a fixed monthly subscription for the AI diagnostic service. The company employs a field-sales-led go-to-market motion targeting quality measure managers, risk adjustment professionals, and clinical leadership at health plans, supported by conference presence at events such as RISE, HEDIS, NAACOS, and MEDICA. Customer logos include United Healthcare, Humana, multiple BCBS plans, Florida Blue, Kaiser, Elevance, Highmark, Geisinger, Dignity Health, Optum, and Molina, with documented case-study outcomes showing Star Ratings improvements tied to MiniOmni deployment.

Name

BeamMed

Legal name

BeamMed Ltd.

Website

https://beammed.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

BeamMed manufactures the Sunlight MiniOmni portable ultrasound bone density scanner and an FDA-cleared AI handheld fundus camera, selling primarily to US Medicare Advantage health plans, health systems, and clinics to support HEDIS quality measures and preventive screening.

Ownership category

akta.pro rank

Product category

Bone Densitometry and Retinal Imaging Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHABAD

Ultrasound & Echography Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

SECONDARYHLAHABAL

Portable, Mobile & Point-of-Care Imaging Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

SECONDARYHLACAPAB

Connected Medical Devices & Wearables (Sensors, Patches, Implantables)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

• Bone density scanners
• Osteoporosis screening devices
• Ultrasound bone densitometry
• Diabetic retinopathy detection
• Portable medical imaging

Headquarters

HQ city

Petah Tikwah

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Bone Density Scanner Hardware Sales: Sale of Sunlight MiniOmni portable bone density scanning devices to healthcare organizations. The company sells devices directly to Medicare Advantage plans, health systems, clinics, and physician practices. Devices are sold with software and come with a carry case for portability.
2. AI Fundus Camera: Sale of AI-powered handheld fundus cameras for diabetic retinopathy detection. The device includes cloud-based AI diagnostic service with a fixed monthly subscription fee. Reimbursable under CPT code 922291.
3. AI Diagnostic Software Service: Cloud-based artificial intelligence service that analyzes fundus images for diabetic retinopathy detection. Provides real-time detection and generates results using a single image from each eye.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

BeamMed develops, manufactures, and sells portable ultrasound-based medical devices for bone density assessment (Sunlight MiniOmni scanner using proprietary Omnipath technology) and a handheld AI-powered fundus camera for diabetic retinopathy detection. The company targets Medicare Advantage and Medicaid health plans, hospitals, clinics, and retail health settings with solutions that enable radiation-free, point-of-care osteoporosis screening and HEDIS quality-measure compliance.

Product overview

BeamMed develops, manufactures, and markets bone health and eye health diagnostic solutions. The product portfolio centers on two core device platforms: the Sunlight MiniOmni portable bone density scanner, which uses proprietary Omnipath ultrasound technology for radiation-free osteoporosis screening and monitoring across multiple skeletal sites, and the AI Fundus Camera, an FDA-cleared handheld retinal imaging device paired with cloud-based AI analysis for diabetic retinopathy detection. Both devices are designed for point-of-care use in physician offices, clinics, hospitals, HMOs, pharmacies, and mobile screening settings. The MiniOmni connects via USB to Windows PCs and is supported by HEDIS quality measure solutions (OMW and OSW) that help Medicare and Medicaid plans improve Star Ratings compliance. The Fundus Camera offers cloud connectivity for AI-powered diagnostic services and a user management portal for result access. Omnipath axial transmission technology underlies the bone density product line, providing the measurement methodology for both portable and fixed bone sonometer devices.

Differentiator

Problem solved

Functional benefit

Brands

• Sunlight: The Sunlight brand and product line, acquired in 2006, includes the Sunlight MiniOmni and Sunlight Omnisense portable bone density assessment devices based on proprietary Omnipath ultrasound technology.
• Sunlight MiniOmni
• AI Fundus Camera

Products and services

• Sunlight MiniOmni Portable Bone Density Scanner An ultra-compact (under 2 lbs) portable ultrasound bone densitometer using BeamMed's proprietary Omnipath axial transmission technology to deliver radiation-free, multi-site (Radius, Phalanx, Metatarsal) osteoporosis screening and monitoring in under a minute, connecting via USB to Windows PCs and exporting reports to EMR. Sold to physician offices, clinics, pharmacies, hospitals, nursing homes, health plans, and at-home screening providers, and used to support HEDIS OMW and OSW quality-measure compliance.
• AI Fundus Camera An FDA-cleared handheld retinal imaging device paired with cloud-based AI computer-vision analysis for detection of more-than-mild diabetic retinopathy. Delivers results in under 60 seconds without pupil dilation, is reimbursable under CPT code 922291, and ships with a User Management Portal for PDF report access and a fixed monthly AI service subscription. Designed for use by any trained healthcare professional in physician offices, clinics, community screenings, and pharmacies.
• HEDIS OMW Quality Measure Solution A bone density screening solution package built around the Sunlight MiniOmni that is designed to help Medicare Advantage and Medicaid plans meet NCQA HEDIS Osteoporosis Management in Women (OMW) quality measures, supporting Star Ratings improvement and quality bonus payments through portable in-office screening.
• HEDIS OSW Quality Measure Solution A bone density screening solution package built around the Sunlight MiniOmni that addresses NCQA HEDIS Osteoporosis Screening in Women (OSW) quality measures for Medicare and Medicaid plans, designed to close quality gaps and support Star Ratings performance.

Quantifiable outcome

• Health plans achieved 5 STAR status in HEDIS OMW quality measure within months of implementing MiniOmni
• +2 more outcomes

Named customers19 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Digital Diagnostics: Developer of IDx-DR, the first FDA-cleared autonomous AI diagnostic for diabetic retinopathy. Directly competes with BeamMed's AI Fundus Camera in AI-based DR screening.
• DMS Imaging: French manufacturer of DXA bone densitometry systems (Stratos, Lexxos) — directly competes with BeamMed in osteoporosis assessment.
• OsteoSys: South Korea-based bone densitometry manufacturer (Sonost, Primus) producing portable and clinical ultrasound bone densitometers — closest Asia-Pacific analogue to BeamMed's product line.
• Hologic: Market-leading DXA bone densitometry manufacturer (Discovery/Horizon). Direct competitor to BeamMed's MiniOmni on the clinical side, dominating hospital and central-lab bone density workflows.
• Eyenuk: Developer of EyeArt, an FDA-cleared AI system for diabetic retinopathy screening used in primary care. Competes with BeamMed's handheld AI fundus camera for the same diabetic-retinopathy screening workflows.
• Echolight: Italy-based developer of REMS (Radiofrequency Echographic Multi Spectrometry) ultrasound bone densitometry technology, offering a direct non-ionizing alternative to DXA — competing head-to-head with BeamMed's Omnipath ultrasound approach.

Broad incumbents

• GE HealthCare: Sells Lunar iDXA bone densitometry systems. As a broad incumbent in medical imaging, GE overlaps with BeamMed in bone density and ultrasound-adjacent imaging categories.
• Topcon Healthcare: Major incumbent in ophthalmic imaging (fundus cameras, OCT). Competes with BeamMed's AI Fundus Camera as an established retinal-imaging vendor adding AI screening capabilities to its installed base.

Emerging players

• AEYE Health: Emerging FDA-cleared AI retinal screening vendor targeting primary care and pharmacy channels — directly adjacent competitor to BeamMed's handheld AI fundus strategy.
• Nano-X Imaging: Israeli company developing low-cost, portable X-ray and imaging devices aimed at democratizing diagnostic imaging. Overlaps with BeamMed's portable, point-of-care screening thesis across multiple modalities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BeamMedLtd
• YouTubeyoutube.com/channel/beammed
• Facebookfacebook.com/beammed
• LinkedInlinkedin.com/company/beammed

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BeamMed